M&A Deal Summary |
|
|---|---|
| Date | 2017-05-23 |
| Target | True North Therapeutics |
| Sector | Life Science |
| Buyer(s) | Bioverativ |
| Deal Type | Add-on Acquisition |
| Deal Value | 400M USD |
SEARCH BY
Bioverativ, Inc. is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |